Education
About Us
Working with TipRanks
Follow Us
USANA Health (USNA)
NYSE:USNA
USNA Stock Chart & Stats
$22.53
-$0.56(-1.60%)
At close: 4:00 PM EST
$22.53
-$0.56(-1.60%)
Day’s Range― - ―
52-Week Range$18.48 - $38.32
Previous CloseN/A
Volume19.92K
Average Volume (3M)173.43K
Market Cap
$367.26M
Enterprise Value$223.07M
Total Cash (Recent Filing)$145.35M
Total Debt (Recent Filing)$0.00
Price to Earnings (P/E)35.9
Beta0.98
Next Earnings
Apr 28, 2026EPS Estimate
0.44Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.60
Shares Outstanding18,280,857
10 Day Avg. Volume170,208
30 Day Avg. Volume173,431
Financial Highlights & Ratios
PEG Ratio-0.48
Price to Book (P/B)1.28
Price to Sales (P/S)0.80
P/FCF Ratio13.36
Enterprise Value/Market Cap0.61
Enterprise Value/Revenue0.24
Enterprise Value/Gross Profit0.32
Enterprise Value/Ebitda2.66
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)1.84
Revenue Forecast (FY)$956.18M
Bulls Say, Bears Say
Bulls Say
Conservative Balance SheetExtremely low leverage gives USANA meaningful financial flexibility to fund growth, weather shocks, and invest in venture brands without debt-service pressure. Over the next 2–6 months this supports capital allocation toward manufacturing, inventory and strategic priorities while limiting financial risk.
Sustained Revenue GrowthTTM revenue growth of about 15% indicates durable top-line momentum across core and venture segments driven by product launches and channel activity. Sustained revenue expansion provides scale to absorb fixed costs and underpins potential margin recovery if Brand Partner productivity stabilizes.
In-house Manufacturing CapabilityBringing Hiya and Rise Bar production in-house is a structural improvement that can lower COGS, shorten lead times, and reduce third-party dependency. Over months this should support more stable gross-margin realization for venture brands and better inventory management as volumes scale.
Bears Say
Margin CompressionNet margin decline to ~1.9% reflects that investments, the enhanced compensation plan, and other costs have materially eroded profitability. Persistently lower margins shrink retained earnings and constrain the firm’s ability to self-fund growth or absorb cyclical downturns without cutting investment or taking other actions.
Weakened Cash GenerationLower operating and free cash flow reduces internal funding for inventory buildup, capex, and venture investments. With management increasing working capital for Hiya and Rise, weaker cash conversion elevates the risk that growth initiatives will require external financing or force tougher prioritization of capital uses.
Direct-selling Execution RiskA decline in Hiya active customers tied to platform algorithm changes and softer Brand Partner productivity exposes a structural dependency on digital acquisition and distributor effectiveness. This makes customer growth and revenue more volatile and may require sustained investment to diversify channels and rebuild acquisition flows.
USANA Health News
USNA FAQ
What was USANA Health’s price range in the past 12 months?
USANA Health lowest stock price was $18.48 and its highest was $38.32 in the past 12 months.
What is USANA Health’s market cap?
USANA Health’s market cap is $367.26M.
When is USANA Health’s upcoming earnings report date?
USANA Health’s upcoming earnings report date is Apr 28, 2026 which is in 55 days.
How were USANA Health’s earnings last quarter?
USANA Health released its earnings results on Feb 17, 2026. The company reported $0.6 earnings per share for the quarter, beating the consensus estimate of $0.41 by $0.19.
Is USANA Health overvalued?
According to Wall Street analysts USANA Health’s price is currently Overvalued.
Does USANA Health pay dividends?
USANA Health does not currently pay dividends.
What is USANA Health’s EPS estimate?
USANA Health’s EPS estimate is 0.44.
How many shares outstanding does USANA Health have?
USANA Health has 18,280,857 shares outstanding.
What happened to USANA Health’s price movement after its last earnings report?
USANA Health reported an EPS of $0.6 in its last earnings report, beating expectations of $0.41. Following the earnings report the stock price went down -8.035%.
Which hedge fund is a major shareholder of USANA Health?
Currently, no hedge funds are holding shares in USNA
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
USANA Health Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Blogger Sentiment
Bullish
USNA Sentiment 75%
Sector Average ―
Sector Average ―
Hedge Fund Trend
Decreased
By 69.9K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Sold Shares
Worth $169.5K over
the Last 3 Months
the Last 3 Months
News Sentiment
Bullish
Bullish news 75%
Bearish news 25%
Bearish news 25%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-41.01%
12-Months-Change
Fundamentals
Return on Equity
3.20%
Trailing 12-Months
Asset Growth
8.24%
Trailing 12-Months
Company Description
USANA Health
USANA Health Sciences, Inc. develops, manufactures, and sells science-based nutritional and personal care products. The company offers USANA nutritional products that comprise essentials/CellSentials, such as vitamin and mineral supplements that provide a foundation of total body nutrition for various age groups; optimizers comprising targeted supplements that are designed to meet cardiovascular, skeletal/structural, and digestive health needs; and foods that include meal replacement shakes, snack bars, and other related products. It also provides Celavive, a skin care regimen for various skin care types and ethnicities; and other products for prenatal, infant, and young child age groups. In addition, the company offers materials and online tools to assist associates in building their businesses, as well as in marketing products. It offers its products directly in the Asia Pacific, the Americas, and Europe, as well as online. The company has a research collaboration agreement with Beijing University of Chinese Medicine for research in the field of traditional Chinese medicine; and National Sports Training Bureau. USANA Health Sciences, Inc. was founded in 1992 and is headquartered in Salt Lake City, Utah.
USNA Earnings Call
Q4 2026
0:00 / 0:00
Earnings Call Sentiment|Neutral
The call presents a mixed but constructive outlook: clear positives include retail wins for Hiya and Rise Wellness, a 4% midpoint sales growth outlook for FY2026, experienced leadership returning to CEO, and cost savings from workforce realignment. Offsetting these positives are meaningful risks — notably a 48% inventory build, a very high effective tax rate guidance of 55–60%, core-business sales declines, and FY2026 margin pressure from venture-brand mix with Rise only expected to breakeven. Management conveyed confidence and a concrete strategic plan, but several financial and execution risks remain that balance the positive operational developments.View all USNA earnings summariesTechnical Analysis
Ownership Overview
41.28% Insiders
11.66% Mutual Funds
11.93% Other Institutional Investors
22.71% Public Companies and
Individual Investors
Options Prices
Currently, No data available
---